Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
Padmashri Naren, Anjali Cholkar, Suchita N. Kamble, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S399-S428
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 40
Microtubule acetylation dyshomeostasis in Parkinson’s disease
Padmashri Naren, Khan Sabiya Samim, Kamatham Pushpa Tryphena, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 25
Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease
Kamatham Pushpa Tryphena, Uppala Sai Nikhil, Poojitha Pinjala, et al.
ACS Chemical Neuroscience (2023)
Closed Access | Times Cited: 24
PET brain imaging in neurological disorders
Lijun Xie, Jihua Zhao, Ye Li, et al.
Physics of Life Reviews (2024) Vol. 49, pp. 100-111
Closed Access | Times Cited: 8
Lactoferrin-modified organic-inorganic hybrid mesoporous silica for co-delivery of levodopa and curcumin in the synergistic treatment of Parkinson's disease
Xiuping Guo, Xiaoguang Qiao, Xinru Li, et al.
Phytomedicine (2025) Vol. 140, pp. 156547-156547
Closed Access | Times Cited: 1
Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics
Sai Nikhil Uppala, Kamatham Pushpa Tryphena, Padmashri Naren, et al.
Mechanisms of Ageing and Development (2023) Vol. 213, pp. 111826-111826
Closed Access | Times Cited: 19
Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
Brain Research (2023) Vol. 1815, pp. 148462-148462
Closed Access | Times Cited: 19
Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Alexander V. Blagov, Anton Y. Postnov, Vasily N. Sukhorukov, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 36-36
Open Access | Times Cited: 7
Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson's disease mouse model
Rachit Jain, Nusrat Begum, Shruti Rajan, et al.
Mitochondrion (2023) Vol. 74, pp. 101824-101824
Open Access | Times Cited: 16
The role of istradefylline in the Parkinson’s disease armamentarium
Thomas Müller
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 7, pp. 863-871
Closed Access | Times Cited: 11
Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease
Shruti Rajan, Anika Sood, Rachit Jain, et al.
Neuroscience Letters (2023) Vol. 820, pp. 137596-137596
Closed Access | Times Cited: 11
From mitochondrial dysfunction to neuroinflammation in Parkinson’s disease: Pathogenesis and mitochondrial therapeutic approaches
Negar Ebadpour, Mahmoud Mahmoudi, Ramiar Kamal Kheder, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113015-113015
Closed Access | Times Cited: 4
Unrevealing the molecular mechanisms of MPTP-induced Parkinson’s in experimental animals
Somnath Mondal, Sayeed Mohammed Firdous
Medicinal Chemistry Research (2025)
Closed Access
Network pharmacology approach to unravel the neuroprotective potential of natural products: a narrative review
Pankaj Kumar Singh, Maheshkumar R. Borkar, Gaurav Doshi
Molecular Diversity (2025)
Closed Access
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?
Jinsong Xue, Keju Tao, Weijia Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1641-1641
Open Access | Times Cited: 3
Diagnostic metabolomic profiling of Parkinson's disease biospecimens
Peter A. LeWitt, Jia Li, Kuan-Han Wu, et al.
Neurobiology of Disease (2022) Vol. 177, pp. 105962-105962
Open Access | Times Cited: 15
Mitochondrion-based organellar therapies for central nervous system diseases
Mengke Zhao, Jiayi Wang, Shuaiyu Zhu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
miR‐221 and Parkinson's disease: A biomarker with therapeutic potential
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Reena Gupta, et al.
European Journal of Neuroscience (2023) Vol. 59, Iss. 2, pp. 283-297
Open Access | Times Cited: 6
Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease
Meng‐Fan Yao, Tao Dang, Huajun Wang, et al.
Behavioural Brain Research (2023) Vol. 459, pp. 114811-114811
Open Access | Times Cited: 5
Calcium/calmodulin-dependent serine protein kinase exacerbates mitochondrial calcium uniporter-related mitochondrial calcium overload by phosphorylating α-synuclein in Parkinson’s disease
Qingxi Zhang, Yin Huang, Anbiao Wu, et al.
The International Journal of Biochemistry & Cell Biology (2023) Vol. 157, pp. 106385-106385
Closed Access | Times Cited: 4
Screening of Crucial Cytosolicproteins Interconnecting the Endoplasmic Reticulum and Mitochondria in Parkinson’s Disease and the Impact of Anti-Parkinson Drugs in the Preservation of Organelle Connectivity
Athira Anirudhan, S. Mahema, Sheikh F. Ahmad, et al.
Brain Sciences (2023) Vol. 13, Iss. 11, pp. 1551-1551
Open Access | Times Cited: 4
The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson’s Disease
Neha Neha, Iqra Mazahir, Sara Akhtar Khan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 8086-8103
Closed Access | Times Cited: 1
Mitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy
Mega Obukohwo Oyovwi, Emeka Ugwuishi, Onoriode Andrew Udi, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Closed Access | Times Cited: 1
In-Silico Screening to Identify Phytochemical Inhibitor for hP2X7: A Crucial Inflammatory Cell Death Mediator in Parkinson’s Disease
Sabiya Samim Khan, Dharmendra Kumar Khatri
Computational Biology and Chemistry (2024) Vol. 115, pp. 108285-108285
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top